Cargando…
Remdesivir analog as SARS-CoV-2 polymerase inhibitor: virtual screening of a database generated by scaffold replacement
By the end of 2019, a novel strain of the corona viral family named SARS-CoV-2 emerged in Wuhan, China and started to spread worldwide causing one of the most dangerous lethal pandemics. Researchers utilized various reported inhibitors and drug databases for virtual screening analysis against this n...
Autores principales: | Said, Mohamed A., Albohy, Amgad, Abdelrahman, Mohamed A., Ibarhim, Hany S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366421/ https://www.ncbi.nlm.nih.gov/pubmed/36105996 http://dx.doi.org/10.1039/d2ra00486k |
Ejemplares similares
-
Importance of glutamine 189 flexibility in SARS-CoV-2 main protease: Lesson learned from in silico virtual screening of ChEMBL database and molecular dynamics
por: Said, Mohamed A., et al.
Publicado: (2021) -
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
por: Lo, Michael K., et al.
Publicado: (2020) -
Remdesivir
por: Bakheit, Ahmed H., et al.
Publicado: (2023) -
New Acaciin-Loaded Self-Assembled Nanofibers as M(Pro) Inhibitors Against BCV as a Surrogate Model for SARS-CoV-2
por: Mohamad, Soad A, et al.
Publicado: (2021) -
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
por: Kokic, Goran, et al.
Publicado: (2021)